Rein Therapeutics (RNTX) Research Hub

Rein Therapeutics (RNTX) trades on NASDAQ, US in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-10-26, shares last closed at 0.5832 USD (+0.19%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.44, market cap 0.02B. This hub links to the full technical, earnings and options research available for RNTX.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Pharmaceuticals)
ExchangeNASDAQ, US
Last close0.5832 USD (+0.19%)
52-week range0.5432 USD – 1.05 USD
Trend regimeRange
14-day RSI26.9 (Oversold)
Trailing P/E-0.44
Market cap0.02B
Dividend yield0.00%
Next earnings2026-08-13

Available research for RNTX

Earnings

RNTX earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -0.44. Updated 2026-07-23.

Options: Covered Call

Covered Call on RNTX: how it works, illustrative setup around the real 0.5832 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on RNTX: how it works, illustrative setup around the real 0.5832 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on RNTX: how it works, illustrative setup around the real 0.5832 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

RNTX technical analysis: range, last 0.5832 USD, RSI 26.9, 52w range 0.5432 USD–1.05 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is RNTX in?

Rein Therapeutics (RNTX) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, US.

Is RNTX in an uptrend or downtrend?

As of 2026-10-26, RNTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is RNTX's trailing P/E ratio?

RNTX's trailing P/E is -0.44, with a market cap of 0.02B. See the earnings research page for full valuation detail.

When does RNTX next report earnings?

RNTX is next scheduled to report earnings on 2026-08-13.